Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,755 total articles
Disney trades at roughly 14x earnings with free cash flow of $7.06B and an EV/EBITDA near 12. With parks demonstrating high margins and streaming finally contributing meaningful operating income, the risk/reward favors buyers. Technicals are deeply oversold and short interest is modest; we upgrade to Buy with a $125 target and $85 stop for a long-t…
Astera Labs (ALAB) has pulled back from last year’s highs into a more constructive setup. Strong AI-driven demand for high-speed networking, expanding product roadmap for Scorpio X-Series switches, solid cash and FCF generation, and bullish technicals create a favorable risk/reward for a mid-term trade. Valuation is rich, but the company’s fundamen…
Gencor (GENC) is a small-cap industrial that looks materially undervalued relative to its earnings power and cash position. Recent revenue softness from delayed federal infrastructure spending masks improving profit margins, a $57.4M backlog and roughly $147.7M in cash and securities on the balance sheet. With a market cap around $213M and no debt,…
Precigen (PGEN) is a small-cap biotech with a recently approved product and a BLA in play for a first-in-class respiratory indication. At a current market price around $4.05 and market cap near $1.43B, the stock offers an asymmetric swing trade: limited immediate downside with a clear catalyst schedule and analyst targets north of $8.00. This trade…
DHT is a cash-generative crude tanker owner with a manageable balance sheet, active fleet optimization and earnings levers coming online. With a market cap of roughly $2.9B, a PE of 13.5 and a dividend yield north of 5.5%, the stock offers asymmetry: modest valuation with upside from higher VLCC utilization and charter rates as newbuilds enter the …
Achieve Life Sciences (ACHV) is a clinical-stage play on cytisinicline, an established plant-based alkaloid for nicotine dependence. With an FDA New Drug Application under review for a June 2026 PDUFA and early signals of a broader vaping-cessation market, we keep a Buy rating and an actionable long trade into the catalyst.
PDD Holdings trades at a low-teens multiple with double-digit growth potential from Pinduoduo and improving Temu economics. Current technicals and insider/large investor interest support a tactical long: entry $101.00, stop $91.00, target $140.00 over a multi-horizon plan. The trade balances valuation, growth, and headline risk tied to internationa…
Nike has been punished to five-year lows, but recent data and management execution point to a nascent recovery that the market is not yet fully pricing. With a $77.6B market cap, a 3.0% dividend yield, improving North American wholesale activity and oversold technicals, a disciplined long with a tight stop offers a favorable risk/reward as the comp…
Community Trust Bancorp (CTBI) looks like a higher-conviction buy after improving asset-quality signals and valuation that still lags larger peers. At roughly $60.26, CTBI trades at ~11x earnings, 1.28x book and yields about 3.3%. Low debt, strong free cash flow and modest ROE leave upside if regional loan performance stays stable. We outline a mid…
EQT is a vertically integrated natural gas producer with strong free cash flow, modest leverage and exposure to growing U.S. gas demand from LNG exports and electrification. Near-term supply shocks and structural demand growth create a favorable setup for a mid-term long trade. This idea outlines an entry at $67.65, a $80 target and a $62 stop with…
Roblox plunged from last summer's highs into the low $50s, but the company's cash generation and ongoing platform improvements create a tactical long opportunity. This trade targets a mid-term rebound while respecting valuation and regulatory risks.
Alphabet's recent push into model/data compression is a genuine game changer for AI infrastructure economics. The market sold off across suppliers, but Alphabet itself is sitting on strong fundamentals, healthy cash flow and attractive technical oversold conditions. This trade targets a disciplined long with a clear entry, stop and target over a 18…
Victoria's Secret & Co. (VSCO) has shown consistent sales recovery, margin expansion and healthy free cash flow. The stock has pulled back from its 52-week high into technical support and offers a controlled risk-reward for a mid-term swing trade. Entry $43.50, stop $38.00, target $55.00 - objective is to capture continued rerating as execution on …
Nebius just locked multi-decade, multi-billion-dollar capacity deals with hyperscalers that materially change its revenue trajectory. The market has punished the stock in the short run, creating a high-risk, high-reward trade: enter at $109.13, target $150.00, stop $95.00, horizon 180 trading days. This is a directional long for disciplined, size-l…
SpaceX's looming IPO is a bullish catalyst for space equities, and Rocket Lab (RKLB) looks set to benefit from renewed investor interest and near-term contract wins. I recommend a tactical long on a measured pullback — entry at $66.00, stop at $58.00, target at $85.00 — over a mid-term horizon (45 trading days). The thesis balances Rocket Lab's exp…
Bayer looks like a classic remediation-to-return story: cost discipline, portfolio pruning and improving fundamentals are starting to show through. This is a position trade that aims to capture a multi-quarter rerating as execution and legal progress validate the thesis.
Banco BBVA Argentina (BBAR) is trading at $14.49 with a market cap of roughly $3.2B and a P/E of 14.9. The bank's operational footprint, conservative book value and recent technical setup argue for a mid-term long trade (45 trading days) targeting a re-rating toward $18, while protecting capital with a $13 stop.
Dynex Capital (DX) is trading near the low end of its range after a rate-driven sell-off. The company's internally managed mortgage portfolio and hedging program have kept earnings and dividend coverage intact (EPS $1.53, ROE 12.5%), and the stock offers a ~9.8% cash yield today. For income-oriented traders willing to tolerate leverage and mark-to-…
Moody's (MCO) is trading below its recent highs after a broad market pullback. With $2.6B in free cash flow, a 60%+ ROE, and recurring Analytics revenue, the business can withstand cyclical issuance slowdowns. Valuation at ~31x earnings and $77B market cap isn't a bargain, but the combination of durable economics and a near-term technical setup sup…
ITA (iShares U.S. Aerospace & Defense ETF) provides concentrated exposure to U.S. defense primes and aerospace suppliers. With renewed geopolitical risk tied to the Iran conflict and credible signals that Europe could be the next escalation front, defense flows can reaccelerate. This trade idea lays out a tactical long in ITA with a clear entry at …
Dycom (DY) offers visible near-term revenue growth tied to a record $9.5B backlog and the recent Power Solutions acquisition. Fundamentals and free cash flow support a mid-term long trade while technicals have pulled back to a constructive entry. Trade plan includes an entry at $341.105, a stop at $320.00 and a target at $390.00 over a mid-term (45…
I closed my Alibaba position at current levels and redeployed capital into JD.com. Alibaba's stock is pricing in a capital-intensive AI pivot with uneven near-term profit outcomes; the shares are under pressure from slowing e-commerce and margin compression even as cloud and chip investments accelerate. The trade here is a mid-term (45 trading days…
Avino Silver & Gold (ASM) looks like a durable mining story: diversified silver/gold/copper exposure, a market cap just above $1.0B, and a history of buybacks. Still, stretched valuation versus recent trading, a weakening technical setup and persistent short interest force a rating downgrade to Neutral. Traders can take a tactical long with tight r…
Palantir's operational story - rapid revenue growth, strong cash flow and expanding enterprise AI partnerships - remains intact. The problem for bulls is valuation: the market is pricing near tech royalty with price-to-sales above 80x and a market cap north of $360B. For traders, that makes a mid-term short attractive if momentum and multiple compr…
Altus Group is a predictable commercial real-estate data and services business that appears oversold after a wave of AI-driven selloffs hit data/tech-exposed names. With predictable recurring revenue, pricing power in niche valuation and tax services, and several near-term catalysts that could restore confidence, this is a mid-term trade with asymm…
